Kailera Therapeutics, Inc.
KLRANASDAQHealthcareBiotechnology
Previous close
$17.17
−$0.29 · -1.66%
KLRA company overview
Regular session · ET · Market data may be delayed.
Company profile
Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Ronald C. Renaud Jr.
- Listed since
- Apr 17, 2026
- Employees
- 145
Market position
Day range
Current $17.17
52-week range
Current $17.17
- Open
- $17.52
- Previous close
- $17.46
- Volume
- 436.83K
- 0.54× average
- Average volume
- 805.63K
- Average daily volume
- Market cap
- 2.22B USD
- Beta
- 0.5
- Market reference 1
- 50-day average
- $19.21
- -10.62% below average
- 200-day average
- $20.6265
- -16.76% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.92B USD
- EV / EBITDA
- -18.46×
- Earnings yield
- -4.86%
- Free cash flow yield
- -3.99%
Profitability & efficiency
- Return on equity
- 41.79%
- Return on assets
- -21.52%
- Return on invested capital
- -24.48%
Financial health
- Current ratio
- 12.01×
Financial statements
| Metric (USD) | FY2025 |
|---|---|
| Research and development | 109.11M USD |
| Selling, general, and administrative | 49.23M USD |
| Operating expenses | 158.34M USD |
| Interest income | 11.05M USD |
| Depreciation and amortization | 310K USD |
| Operating income | −158.34M USD |
| Net income | −148.96M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 0%
- 0 beats, 2 misses, 0 met estimates
- Average EPS surprise
- -235444.65%
- 2 comparable reports
- Latest EPS result
- -1.09
- Estimate -0.9 · Miss by 21.56%
EPS: actual versus estimate
Recent quarterly results
KLRA peers
ETFs holding KLRA
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM20.25M0.03%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI20M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB14.44M0.01%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK8.29M0.02%43.8B USD0.05%$358.65+0.70%
Vanguard Extended Market ETFVXF8.08M0.01%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Growth ETFIWO5.09M0.03%15.16B USD0.24%$387.37+1.24%
Vanguard Russell 2000 ETFVTWO4.39M0.02%17.4B USD0.06%$121.25+0.74%
Schwab U.S. Small-Cap ETFSCHA3.34M0.01%23.1B USD0.03%$34.83+0.52%iShares Russell 2000 ETFIWM- Market value
- 20.25M
- Weight
- 0.03%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 20M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 14.44M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 8.29M
- Weight
- 0.02%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Vanguard Extended Market ETFVXF- Market value
- 8.08M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Growth ETFIWO- Market value
- 5.09M
- Weight
- 0.03%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Vanguard Russell 2000 ETFVTWO- Market value
- 4.39M
- Weight
- 0.02%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 3.34M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Continue in GoAI
Research KLRAresearch.disclaimer